ATLANTIS INDUSTRIES, LLC – Trademark Portfolio
Entity Type: 16
ATLANTIS INDUSTRIES, LLC holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 20 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 17 trademarks are registered and 1 is pending. Notable registered marks include HEED, AMINO AGE, PERPETUEM, HAMMER BAR, and HAMMER GEL. The owner is based in WHITEFISH, MT.
1018 CREEK VIEW DRIVE
WHITEFISH, MT 59937
Showing of trademarks Trademarks
Trademark Classifications
ATLANTIS INDUSTRIES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ATLANTIS INDUSTRIES, LLC have?
ATLANTIS INDUSTRIES, LLC has 21 U.S. trademarks filed with the USPTO. Of these, 17 registered, 1 pending, 1 abandoned, 2 cancelled.
What trademark classes does ATLANTIS INDUSTRIES, LLC file in?
ATLANTIS INDUSTRIES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ATLANTIS INDUSTRIES, LLC's most well-known trademarks?
ATLANTIS INDUSTRIES, LLC's registered trademark portfolio includes well-known marks such as HEED, AMINO AGE, PERPETUEM, HAMMER BAR, and HAMMER GEL. These are among 17 currently registered trademarks in the portfolio.
What is ATLANTIS INDUSTRIES, LLC's trademark registration success rate?
ATLANTIS INDUSTRIES, LLC has a 85% trademark registration rate, with 17 out of 20 resolved applications resulting in successful registration. Currently, 1 application is pending review.